Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-06

Clinical Trial Update: Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne [Phase 2]

View source ↗

Summary

Phase 2 study assessing the safety and efficacy of a topical combination of clindamycin, benzoyl peroxide, and tazarotene for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin/Benzoyl Peroxide/Tazarotene Cream

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06